David Garratt, principal consultant - Automated IT Governance, Risk, Compliance, Verista looks at building a practical AI governance foundation in regulated industries.
Leica Biosystems announced the addition of two Paige digital pathology AI-enabled products from Tempus to its Aperio AI Store—a unified, interoperable digital pathology platform that provides multiple AI-powered applications in a single interface.
Phesi has launched a new Protocol Complexity analysis module within its AI-powered Trial Accelerator platform that lets sponsors identify and reduce protocol complexity before it drives up cost, timelines and execution risk.
The latest research from LogiPharma has revealed that AI and machine learning are top investment priorities for pharmaceutical supply chain leaders, with advanced data analytics following behind as a key priority for 73% of respondents.
Jason Bryant, general manager of AI platforms at ArisGlobal, and Samuel Wallis, head of case processing at Bristol Myers Squibb, argue that pharmacovigilance teams need a formal measure of trust in validated AI systems.
Emerson has announced PACEdge version 3.0, the latest advancement to its IIoT enablement software platform, helping to bring AI capabilities and frictionless application deployment to edge devices.
Median Technologies has announced the signing of a strategic commercial partnership with Canon Medical Systems Corporation through Canon’s subsidiary Olea Medical.
Steriline is enhancing and strengthening the use of AI in its solutions, and is introducing two intelligent technologies that work in synergy: OmniAI Vision and OptiLAIN.
Cognizant has announced it has been selected by Novartis for a five-year, AI-enabled integrated IT operations engagement, expanding a strategic relationship that spans more than 20 years.
When pharmaceutical facilities can cost hundreds of millions of euros, getting the numbers right from the outset is critical. Boehringer Ingelheim explains how it is combining AI, historical project data and robust governance.
